투석환자 보호자 사용기 입니다
좋아요-^^ 주3회 투석환자 보호자 입니다 혈압 등 혈액 정보 기입 시 유용합니다 개발자 및 관리자 분들의 건강도 안녕하시길 바랍니다 🙏🏻🙏🏻
Description
要管理血糖，血压，糖尿病等？
你看这里写血日记。
您可以创建一个日记容易和方便使用的日历。
您还可以录制你喜欢写日记的注释。
您可以创建在当天的多个条目。
只有血压，血糖，体重之一，你可以创建。
将在糖尿病管理的应用程序非常有用。
最近的数据显示图表。
你看这里写血日记。
您可以创建一个日记容易和方便使用的日历。
您还可以录制你喜欢写日记的注释。
您可以创建在当天的多个条目。
只有血压，血糖，体重之一，你可以创建。
将在糖尿病管理的应用程序非常有用。
最近的数据显示图表。
Screenshots
日记血液（糖尿病日记） FAQ
-
Is 日记血液（糖尿病日记） free?
Yes, 日记血液（糖尿病日记） is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 日记血液（糖尿病日记） legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 日记血液（糖尿病日记） cost?
日记血液（糖尿病日记） is free.
-
What is 日记血液（糖尿病日记） revenue?
To get estimated revenue of 日记血液（糖尿病日记） app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in China yet.
Ratings History
日记血液（糖尿病日记） Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
혈액일기 ( 당뇨 수첩 ) Installs
Last 30 days
혈액일기 ( 당뇨 수첩 ) Revenue
Last 30 days日记血液（糖尿病日记） Revenue and Downloads
Gain valuable insights into 혈액일기 ( 당뇨 수첩 ) performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
-
Seong Eon Kim
- Languages
- English, Korean
- Recent release
- 3.3.7 (7 months ago )
- Released on
- Oct 4, 2014 (10 years ago )
- Also available in
- South Korea, United States, Germany, Italy, Vietnam, Netherlands, Denmark, Finland, Mexico, Sweden, Thailand, Switzerland, Canada, Israel, Greece, Japan, Colombia, Czechia, China, New Zealand, Portugal
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.